A Randomized Phase II Trial of Fludarabine/Melphalan 100 versus Fludarabine/Melphalan 140 Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Multiple Myeloma

Qaiser Bashir; Hassan Khan; Peter F. Thall; Ping Liu; Nina Shah; Partow Kebriaei; Simrit Parmar; Betul Oran; Stefan Ciurea; Yago Nieto; Roy Jones; Chitra M. Hosing; Uday R. Popat; Yvonne T. Dinh; Gabriela Rondon; Robert Z. Orlowski; Jatin J. Shah; Marcos De Lima; Elizabeth Shpall; Richard Champlin; Sergio Giralt; Muzaffar H. Qazilbash

doi:10.1016/j.bbmt.2013.07.008

A Randomized Phase II Trial of Fludarabine/Melphalan 100 versus Fludarabine/Melphalan 140 Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Multiple Myeloma

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2013.07.008 ◽

2013 ◽

Vol 19 (10) ◽

pp. 1453-1458 ◽

Cited By ~ 14

Author(s):

Qaiser Bashir ◽

Hassan Khan ◽

Peter F. Thall ◽

Ping Liu ◽

Nina Shah ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Phase Ii ◽

Phase Ii Trial ◽

Hematopoietic Stem ◽

Randomized Phase Ii

Download Full-text

Clofarabine and Treosulfan as Conditioning for Matched Related and Unrelated Hematopoietic Stem Cell Transplantation: Results from the Clo3o Phase II Trial

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2019.09.032 ◽

2020 ◽

Vol 26 (2) ◽

pp. 316-322

Author(s):

Jacopo Peccatori ◽

Sara Mastaglio ◽

Fabio Giglio ◽

Raffaella Greco ◽

Roberto Crocchiolo ◽

...

Keyword(s):

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Phase Ii ◽

Phase Ii Trial ◽

Hematopoietic Stem

Download Full-text

Results of a Phase II Study of Propylene Glycol (PG)-Free, Captisol-Enabled Melphalan Conditioning for Autologous Hematopoietic Stem Cell Transplantation (AHCT) in Patients with Multiple Myeloma (MM)

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2014.11.190 ◽

2015 ◽

Vol 21 (2) ◽

pp. S138 ◽

Cited By ~ 1

Author(s):

Parameswaran N. Hari ◽

Omar Ajitawi ◽

Carlos Arce-Lara ◽

Rajneesh Nath ◽

Natalie Callander ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Stem Cell Transplantation ◽

Propylene Glycol ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Hematopoietic Stem

Download Full-text

A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis after Allogeneic Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2014.11.516 ◽

2015 ◽

Vol 21 (2) ◽

pp. S324 ◽

Cited By ~ 1

Author(s):

Sally Arai ◽

Joseph Pidala ◽

Iskra Pusic ◽

Xiaoyu Chai ◽

Samantha Jaglowski ◽

...

Keyword(s):

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Hematopoietic Stem ◽

Randomized Phase Ii

Download Full-text

Repurposing Nilotinib for Cytomegalovirus Infection Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Arm, Phase II Trial

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2018.07.013 ◽

2018 ◽

Vol 24 (11) ◽

pp. 2310-2315 ◽

Cited By ~ 1

Author(s):

Chien-Ting Lin ◽

Po-Ren Hsueh ◽

Shang-Ju Wu ◽

Ming Yao ◽

Bor-Sheng Ko ◽

...

Keyword(s):

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Phase Ii ◽

Cytomegalovirus Infection ◽

Phase Ii Trial ◽

Infection Prophylaxis ◽

Hematopoietic Stem

Download Full-text

Prospective phase II trial to evaluate the complications and kinetics of chimerism induction following allogeneic hematopoietic stem cell transplantation with fludarabine and busulfan

American Journal of Hematology ◽

10.1002/ajh.20977 ◽

2007 ◽

Vol 82 (10) ◽

pp. 873-880 ◽

Cited By ~ 12

Author(s):

Akiko M. Saito ◽

Masahiro Kami ◽

Shin-Ichiro Mori ◽

Yoshinobu Kanda ◽

Ritsuro Suzuki ◽

...

Keyword(s):

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Phase Ii ◽

Phase Ii Trial ◽

Hematopoietic Stem ◽

Prospective Phase ◽

Kinetics Of

Download Full-text

Autologous hematopoietic stem cell transplantation in multiple sclerosis: A phase II trial

Neurology ◽

10.1212/wnl.0000000000001329 ◽

2015 ◽

Vol 84 (10) ◽

pp. 981-988 ◽

Cited By ~ 121

Author(s):

G. L. Mancardi ◽

M. P. Sormani ◽

F. Gualandi ◽

A. Saiz ◽

E. Carreras ◽

...

Keyword(s):

Multiple Sclerosis ◽

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Phase Ii ◽

Phase Ii Trial ◽

Hematopoietic Stem

Download Full-text

Phase II Trial: The Combination of Tacrolimus, Sirolimus, and Rabbit Anti-Thymocyte Globulin (Thymoglobulin® Thymo) to Prevent Acute Graft-vs.-Host Disease (aGVHD) in Patients Receiving Unrelated Hematopoietic Stem Cell Transplantation (UHSCT)

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2010.12.417 ◽

2011 ◽

Vol 17 (2) ◽

pp. S291

Author(s):

Z. Al-Kadhimi ◽

Z. Gul ◽

R. Rodriguez ◽

W. Chen ◽

A. Mitchell ◽

...

Keyword(s):

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Phase Ii ◽

Phase Ii Trial ◽

Hematopoietic Stem ◽

Graft Vs Host Disease ◽

Acute Graft

Download Full-text

Phase II Trial of Reduced Intensity Busulfan / Clofarabine Conditioning with Allogeneic Hematopoietic Stem Cell Transplantation for Patients with AML, MDS, and ALL

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2013.12.367 ◽

2014 ◽

Vol 20 (2) ◽

pp. S217-S218

Author(s):

Yi-Bin Chen ◽

Shuli Li ◽

Candice Del Rio ◽

Erin Coughlin ◽

Karen K. Ballen ◽

...

Keyword(s):

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Phase Ii ◽

Phase Ii Trial ◽

Hematopoietic Stem ◽

Reduced Intensity

Download Full-text

Bortezomib-based immunosuppression after reduced-intensity conditioning hematopoietic stem cell transplantation: randomized phase II results

Haematologica ◽

10.3324/haematol.2017.176859 ◽

2018 ◽

Vol 103 (3) ◽

pp. 522-530 ◽

Cited By ~ 17

Author(s):

John Koreth ◽

Haesook T. Kim ◽

Paulina B. Lange ◽

Samuel J. Poryanda ◽

Carol G. Reynolds ◽

...

Keyword(s):

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Phase Ii ◽

Reduced Intensity Conditioning ◽

Hematopoietic Stem ◽

Randomized Phase Ii ◽

Reduced Intensity

Download Full-text

Human medicines European public assessment report (EPAR): Mozobil, plerixafor, Multiple Myeloma,Hematopoietic Stem Cell Transplantation,Lymphoma, Date of authorisation: 30/07/2009, Revision: 17, Status: Authorised

Case Medical Research ◽

10.31525/cmr-5871bb ◽

2019 ◽

Author(s):

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Hematopoietic Stem ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text